| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -5.08M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MDNAF returned -60.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -53.6% |
| 1 year | -60.4% |
| 5 years | -87.1% |
| All-time high | $5.10 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MDNAF would be worth today ›No. Medicenna Therapeutics Corp. has not paid a dividend in the past 12 months.
Medicenna Therapeutics Corp. is part of the Healthcare sector.
Medicenna Therapeutics Corp. has a market cap of 28.98M USD, based on the latest quote.
Medicenna Therapeutics Corp. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
